VCYT
Veracyte Inc
NASDAQ: VCYT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$32.92
+3.59% today
Updated 2026-04-30
Market cap
$2.67B
P/E ratio
40.77
P/S ratio
5.16x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$23 – $51
Volume
0.9M
WallStSmart proprietary scores
56
out of 100
Grade: C+
Hold
Investment rating
9.3
Growth
A+9.0
Quality
A+5.5
Profitability
C+6.3
Valuation
B4/9
Piotroski F-Score
Moderate
6.1
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$46.55
+41.40%
12-Month target
$25.71
-21.90%
Intrinsic (DCF)
$77.44
Margin of safety
+53.53%
1 Strong Buy8 Buy2 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 6.05 — safe zone
+ Free cash flow $48.27M — positive
+ Revenue growth 18.50% QoQ
+ 53.53% below intrinsic value
+ Debt/equity 0.03x — low leverage
Risks
- P/E 40.77x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $296.54M | $361.05M | $445.76M | $517.14M | $517.14M |
| Net income | $-36.56M | $-74.40M | $24.14M | $66.35M | $41.15M |
| EPS | — | — | — | — | $0.82 |
| Free cash flow | $-1.01M | $34.26M | $63.81M | $126.63M | $48.27M |
| Profit margin | -12.33% | -20.61% | 5.41% | 12.83% | 12.80% |
Peer comparison
Smart narrative
Veracyte Inc trades at $32.92. representing a P/E of 40.77x trailing earnings. Our Smart Value Score of 56/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 6.05, it sits in the safe zone. TTM revenue stands at $517.14M. with profit margins at 12.80%. Our DCF model estimates intrinsic value at $77.44.
Frequently asked questions
What is Veracyte Inc's stock price?
Veracyte Inc (VCYT) trades at $32.92.
Is Veracyte Inc overvalued?
Smart Value Score 56/100 (Grade C+, Hold). DCF value $77.44.
What is the price target of Veracyte Inc (VCYT)?
The analyst target price is $46.55, representing +41.4% upside from the current price of $32.92.
What is the intrinsic value of Veracyte Inc (VCYT)?
Based on our DCF model, intrinsic value is $77.44, a +53.5% margin of safety versus $32.92.
What is Veracyte Inc's revenue?
TTM revenue is $517.14M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
6.05 — safe zone.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio5.16x
ROE5.34%
Beta1.96
50D MA$33.62
200D MA$35.42
Shares out0.08B
Float0.08B
Short ratio—
Avg volume0.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—